# Accelerating Drug Discovery Through Agentic AI: A Multi-Agent Approach to Laboratory Automation in the DMTA Cycle

arXiv: https://arxiv.org/abs/2507.09023 · HTML: https://mlsanity.com/paper/2507.09023/

## Key facts

- Cited by 6 papers in the map (data through 14 Oct 2026).
- Placed in Medical and scientific domain agents, one of 16 directions in LLM agents and tool use.
- Builds on 3 of its 19 references that are in the map.
- First posted on arXiv 11 Jul 2025.

## Placed in

- LLM agents and tool use / [Medical and scientific domain agents](https://mlsanity.com/agents/medical-and-scientific-domain-agents/)

## Builds on (most cited first, 3 of 3)

- [Deep Learning Methods for Small Molecule Drug Discovery: A Survey](https://mlsanity.com/paper/2303.00313/) (2023)
- [Accelerating drug discovery with Artificial: a whole-lab orchestration and scheduling system for self-driving labs](https://mlsanity.com/paper/2504.00986/) (2025)
- [Uncovering Bottlenecks and Optimizing Scientific Lab Workflows with Cycle Time Reduction Agents](https://mlsanity.com/paper/2505.21534/) (2025)

## Built on by (most cited first, 6 of 6)

- [From AI for Science to Agentic Science: A Survey on Autonomous Scientific Discovery](https://mlsanity.com/paper/2508.14111/) (2025)
- [Multi-agent systems for chemical engineering: A review and perspective](https://mlsanity.com/paper/2508.07880/) (2025)
- [MolLingo: Molecule-Native Representations for LLM-Powered Scientific Agents](https://mlsanity.com/paper/2605.27853/) (2026)
- [Technical Implementation of Tippy: Multi-Agent Architecture and System Design for Drug Discovery Laboratory Automation](https://mlsanity.com/paper/2507.17852/) (2025)
- [Paper Circle: An Open-source Multi-agent Research Discovery and Analysis Framework](https://mlsanity.com/paper/2604.06170/) (2026)
- [Spacer: Towards Engineered Scientific Inspiration](https://mlsanity.com/paper/2508.17661/) (2025)

## Abstract (arXiv)

The pharmaceutical industry faces unprecedented challenges in drug discovery, with traditional approaches struggling to meet modern therapeutic development demands. This paper introduces a novel AI framework, Tippy, that transforms laboratory automation through specialized AI agents operating within the Design-Make-Test-Analyze (DMTA) cycle. Our multi-agent system employs five specialized agents - Supervisor, Molecule, Lab, Analysis, and Report, with Safety Guardrail oversight - each designed to excel in specific phases of the drug discovery pipeline. Tippy represents the first production-ready implementation of specialized AI agents for automating the DMTA cycle, providing a concrete example of how AI can transform laboratory workflows. By leveraging autonomous AI agents that reason, plan, and collaborate, we demonstrate how Tippy accelerates DMTA cycles while maintaining scientific rigor essential for pharmaceutical research. The system shows significant improvements in workflow efficiency, decision-making speed, and cross-disciplinary coordination, offering a new paradigm for AI-assisted drug discovery.